Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Relative Mean Transit Time Predicts Subsequent Stroke in Symptomatic Carotid Occlusion.

Grubb RL Jr, Derdeyn CP, Videen TO, Carpenter DA, Powers WJ.

J Stroke Cerebrovasc Dis. 2016 Jun;25(6):1421-4. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.041. Epub 2016 Mar 22.

PMID:
27021040
2.

Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia.

Powers WJ, Clarke WR, Grubb RL Jr, Videen TO, Adams HP Jr, Derdeyn CP; COSS Investigators.

Neurology. 2014 Mar 25;82(12):1027-32. doi: 10.1212/WNL.0000000000000238. Epub 2014 Feb 14.

3.

Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: main results.

Marshall RS, Festa JR, Cheung YK, Pavol MA, Derdeyn CP, Clarke WR, Videen TO, Grubb RL, Slane K, Powers WJ, Lazar RM; RECON Investigators.

Neurology. 2014 Mar 4;82(9):744-51. doi: 10.1212/WNL.0000000000000167. Epub 2014 Jan 29.

4.

Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.

Karimi M, Moerlein SM, Videen TO, Su Y, Flores HP, Perlmutter JS.

Mov Disord. 2013 Dec;28(14):2002-6. doi: 10.1002/mds.25720. Epub 2013 Oct 21.

5.

Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases.

Campbell MC, Markham J, Flores H, Hartlein JM, Goate AM, Cairns NJ, Videen TO, Perlmutter JS.

Neurology. 2013 Aug 6;81(6):520-7. doi: 10.1212/WNL.0b013e31829e6f94. Epub 2013 Jul 3.

6.

Validation of nigrostriatal positron emission tomography measures: critical limits.

Karimi M, Tian L, Brown CA, Flores HP, Loftin SK, Videen TO, Moerlein SM, Perlmutter JS.

Ann Neurol. 2013 Mar;73(3):390-6. doi: 10.1002/ana.23798. Epub 2013 Feb 19.

7.

Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinson's disease.

Hill KK, Campbell MC, McNeely ME, Karimi M, Ushe M, Tabbal SD, Hershey T, Flores HP, Hartlein JM, Lugar HM, Revilla FJ, Videen TO, Earhart GM, Perlmutter JS.

Exp Neurol. 2013 Mar;241:105-12. doi: 10.1016/j.expneurol.2012.12.003. Epub 2012 Dec 19.

8.

Surgical results of the Carotid Occlusion Surgery Study.

Grubb RL Jr, Powers WJ, Clarke WR, Videen TO, Adams HP Jr, Derdeyn CP; Carotid Occlusion Surgery Study Investigators.

J Neurosurg. 2013 Jan;118(1):25-33. doi: 10.3171/2012.9.JNS12551. Epub 2012 Oct 26.

9.

Thalamic activation during slightly subphysiological glycemia in humans.

Arbeláez AM, Rutlin JR, Hershey T, Powers WJ, Videen TO, Cryer PE.

Diabetes Care. 2012 Dec;35(12):2570-4. doi: 10.2337/dc12-0297. Epub 2012 Aug 13.

10.

Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.

Eisenstein SA, Koller JM, Piccirillo M, Kim A, Antenor-Dorsey JA, Videen TO, Snyder AZ, Karimi M, Moerlein SM, Black KJ, Perlmutter JS, Hershey T.

Synapse. 2012 Sep;66(9):770-80. doi: 10.1002/syn.21566. Epub 2012 May 15.

11.

Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

Campbell MC, Black KJ, Weaver PM, Lugar HM, Videen TO, Tabbal SD, Karimi M, Perlmutter JS, Hershey T.

J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):28-36. doi: 10.1176/appi.neuropsych.11030060.

12.

Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels.

Criswell SR, Perlmutter JS, Crippin JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA.

Arch Neurol. 2012 Mar;69(3):394-7. doi: 10.1001/archneurol.2011.771.

13.

Cerebral hemodynamics and cognitive impairment: baseline data from the RECON trial.

Marshall RS, Festa JR, Cheung YK, Chen R, Pavol MA, Derdeyn CP, Clarke WR, Videen TO, Grubb RL, Adams HP, Powers WJ, Lazar RM.

Neurology. 2012 Jan 24;78(4):250-5. doi: 10.1212/WNL.0b013e31824365d3. Epub 2012 Jan 11.

14.

Effect of osmotic agents on regional cerebral blood flow in traumatic brain injury.

Scalfani MT, Dhar R, Zazulia AR, Videen TO, Diringer MN.

J Crit Care. 2012 Oct;27(5):526.e7-12. doi: 10.1016/j.jcrc.2011.10.008. Epub 2011 Dec 15.

15.

Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage.

Dhar R, Scalfani MT, Zazulia AR, Videen TO, Derdeyn CP, Diringer MN.

J Neurosurg. 2012 Mar;116(3):648-56. doi: 10.3171/2011.9.JNS11691. Epub 2011 Nov 18.

16.

Effect of mannitol on cerebral blood volume in patients with head injury.

Diringer MN, Scalfani MT, Zazulia AR, Videen TO, Dhar R, Powers WJ.

Neurosurgery. 2012 May;70(5):1215-8; discussion 1219. doi: 10.1227/NEU.0b013e3182417bc2.

17.

Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial.

Powers WJ, Clarke WR, Grubb RL Jr, Videen TO, Adams HP Jr, Derdeyn CP; COSS Investigators.

JAMA. 2011 Nov 9;306(18):1983-92. doi: 10.1001/jama.2011.1610. Erratum in: JAMA. 2011 Dec 28;306(24):2672. Obviagele, Bruce [corrected to Ovbiagele, Bruce].

18.

Poor correlation between perihematomal MRI hyperintensity and brain swelling after intracerebral hemorrhage.

Zazulia AR, Videen TO, Diringer MN, Powers WJ.

Neurocrit Care. 2011 Dec;15(3):436-41. doi: 10.1007/s12028-011-9578-8.

19.

Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure.

Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA.

Neurology. 2011 Apr 12;76(15):1296-301. doi: 10.1212/WNL.0b013e3182152830. Epub 2011 Apr 6.

20.

Metabolic control of resting hemispheric cerebral blood flow is oxidative, not glycolytic.

Powers WJ, Videen TO, Markham J, Walter V, Perlmutter JS.

J Cereb Blood Flow Metab. 2011 May;31(5):1223-8. doi: 10.1038/jcbfm.2011.5. Epub 2011 Feb 9.

21.

Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke.

Diringer MN, Scalfani MT, Zazulia AR, Videen TO, Dhar R.

Neurocrit Care. 2011 Feb;14(1):11-7. doi: 10.1007/s12028-010-9465-8.

22.

Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?

Karimi M, Moerlein SM, Videen TO, Luedtke RR, Taylor M, Mach RH, Perlmutter JS.

Mov Disord. 2011 Jan;26(1):100-6. doi: 10.1002/mds.23401. Epub 2010 Oct 19.

23.

Platelet mitochondrial complex I and I+III activities do not correlate with cerebral mitochondrial oxidative metabolism.

Powers WJ, Haas RH, Le T, Videen TO, Markham J, Perlmutter JS.

J Cereb Blood Flow Metab. 2011 Jan;31(1):e1-5. doi: 10.1038/jcbfm.2010.179. Epub 2010 Oct 20.

24.

Mapping Go-No-Go performance within the subthalamic nucleus region.

Hershey T, Campbell MC, Videen TO, Lugar HM, Weaver PM, Hartlein J, Karimi M, Tabbal SD, Perlmutter JS.

Brain. 2010 Dec;133(Pt 12):3625-34. doi: 10.1093/brain/awq256. Epub 2010 Sep 20.

25.

Autoregulation of cerebral blood flow to changes in arterial pressure in mild Alzheimer's disease.

Zazulia AR, Videen TO, Morris JC, Powers WJ.

J Cereb Blood Flow Metab. 2010 Nov;30(11):1883-9. doi: 10.1038/jcbfm.2010.135. Epub 2010 Aug 25.

26.

Dynamic susceptibility contrast MRI with localized arterial input functions.

Lee JJ, Bretthorst GL, Derdeyn CP, Powers WJ, Videen TO, Snyder AZ, Markham J, Shimony JS.

Magn Reson Med. 2010 May;63(5):1305-14. doi: 10.1002/mrm.22338.

27.

Cerebellum as the normal reference for the detection of increased cerebral oxygen extraction.

Jiang TT, Videen TO, Grubb RL Jr, Powers WJ, Derdeyn CP.

J Cereb Blood Flow Metab. 2010 Oct;30(10):1767-76. doi: 10.1038/jcbfm.2010.43. Epub 2010 Apr 7.

28.

Autoregulation after ischaemic stroke.

Powers WJ, Videen TO, Diringer MN, Aiyagari V, Zazulia AR.

J Hypertens. 2009 Nov;27(11):2218-22. doi: 10.1097/HJH.0b013e328330a9a7.

29.

Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage.

Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN.

Stroke. 2009 Sep;40(9):3039-44. doi: 10.1161/STROKEAHA.109.556159. Epub 2009 Jul 23.

30.

Very Early Constraint-Induced Movement during Stroke Rehabilitation (VECTORS): A single-center RCT.

Dromerick AW, Lang CE, Birkenmeier RL, Wagner JM, Miller JP, Videen TO, Powers WJ, Wolf SL, Edwards DF.

Neurology. 2009 Jul 21;73(3):195-201. doi: 10.1212/WNL.0b013e3181ab2b27. Epub 2009 May 20.

31.

Cerebral hemodynamics as a predictor of stroke in adult patients with moyamoya disease: a prospective observational study.

Zipfel GJ, Sagar J, Miller JP, Videen TO, Grubb RL Jr, Dacey RG Jr, Derdeyn CP.

Neurosurg Focus. 2009 Apr;26(4):E6. doi: 10.3171/2009.01.FOCUS08305.

32.

Transient focal increase in perihematomal glucose metabolism after acute human intracerebral hemorrhage.

Zazulia AR, Videen TO, Powers WJ.

Stroke. 2009 May;40(5):1638-43. doi: 10.1161/STROKEAHA.108.536037. Epub 2009 Mar 12.

PMID:
19286594
33.

Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease.

Karimi M, Golchin N, Tabbal SD, Hershey T, Videen TO, Wu J, Usche JW, Revilla FJ, Hartlein JM, Wernle AR, Mink JW, Perlmutter JS.

Brain. 2008 Oct;131(Pt 10):2710-9. doi: 10.1093/brain/awn179. Epub 2008 Aug 12.

34.

Cerebral mitochondrial metabolism in early Parkinson's disease.

Powers WJ, Videen TO, Markham J, Black KJ, Golchin N, Perlmutter JS.

J Cereb Blood Flow Metab. 2008 Oct;28(10):1754-60. doi: 10.1038/jcbfm.2008.63. Epub 2008 Jun 25.

35.

Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.

Antenor-Dorsey JA, Markham J, Moerlein SM, Videen TO, Perlmutter JS.

Nucl Med Biol. 2008 Apr;35(3):335-41. doi: 10.1016/j.nucmedbio.2007.12.004.

36.

Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates.

Antenor-Dorsey JA, Laforest R, Moerlein SM, Videen TO, Perlmutter JS.

Eur J Nucl Med Mol Imaging. 2008 Apr;35(4):771-8. Epub 2007 Dec 11. Erratum in: Eur J Nucl Med Mol Imaging. 2013 May;40(5):795-6. Dosage error in published abstract; MEDLINE/PubMed abstract corrected.

37.

Validation of a fiducial-based atlas localization method for deep brain stimulation contacts in the area of the subthalamic nucleus.

Videen TO, Campbell MC, Tabbal SD, Karimi M, Hershey T, Perlmutter JS.

J Neurosci Methods. 2008 Mar 15;168(2):275-81. Epub 2007 Oct 23.

38.
39.

Normal platelet mitochondrial complex I activity in Huntington's disease.

Powers WJ, Haas RH, Le T, Videen TO, Hershey T, McGee-Minnich L, Perlmutter JS.

Neurobiol Dis. 2007 Jul;27(1):99-101. Epub 2007 May 5.

40.

Patterns of infarction in hemodynamic failure.

Derdeyn CP, Carpenter DA, Videen TO, Grubb RL Jr, Powers WJ.

Cerebrovasc Dis. 2007;24(1):11-9. Epub 2007 May 22.

PMID:
17519539
41.

Effect of hyperoxia on cerebral metabolic rate for oxygen measured using positron emission tomography in patients with acute severe head injury.

Diringer MN, Aiyagari V, Zazulia AR, Videen TO, Powers WJ.

J Neurosurg. 2007 Apr;106(4):526-9.

PMID:
17432700
42.

No effect of low-dose statins treatment on cerebral blood flow in humans with atherosclerotic cerebrovascular disease.

Derdeyn CP, Carpenter DA, Videen TO, Grubb RL Jr, Powers WJ.

J Cereb Blood Flow Metab. 2007 Sep;27(9):1643-8. Epub 2007 Mar 14.

43.

Selective defect of in vivo glycolysis in early Huntington's disease striatum.

Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Dorsey JV, Hershey T, Perlmutter JS.

Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2945-9. Epub 2007 Feb 13.

44.

Symptomatic autoregulatory failure in acute ischemic stroke.

Zazulia AR, Videen TO, Powers WJ.

Neurology. 2007 Jan 30;68(5):389-90. No abstract available.

PMID:
17261690
45.

[18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies.

Racette BA, Good L, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Perlmutter JS.

Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):245-9.

46.

Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage.

Jost SC, Diringer MN, Zazulia AR, Videen TO, Aiyagari V, Grubb RL, Powers WJ.

J Neurosurg. 2005 Jul;103(1):25-30.

PMID:
16121969
47.

[18F]FDOPA PET and clinical features in parkinsonism due to manganism.

Racette BA, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Kotagal V, Perlmutter JS.

Mov Disord. 2005 Apr;20(4):492-6.

PMID:
15648057
48.

Pathophysiology of parkinsonism due to hydrocephalus.

Racette BA, Esper GJ, Antenor J, Black KJ, Burkey A, Moerlein SM, Videen TO, Kotagal V, Ojemann JG, Perlmutter JS.

J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1617-9.

49.

Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia.

Teves D, Videen TO, Cryer PE, Powers WJ.

Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6217-21. Epub 2004 Mar 16.

50.

Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD.

Hershey T, Revilla FJ, Wernle AR, McGee-Minnich L, Antenor JV, Videen TO, Dowling JL, Mink JW, Perlmutter JS.

Neurology. 2003 Sep 23;61(6):816-21.

PMID:
14504327

Supplemental Content

Loading ...
Support Center